Siga Technologies (United States)
SIGA Technologies, Inc. is an American pharmaceutical company founded in 1995, based in New York City, which develops and sells pharmaceutical solutions for the antiviral treatment of smallpox, monkeypox, cowpox, and vaccinia complications. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Siga Technologies (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
72%
Total
Publications
121
Total Open
Publications
87
Total
Citations
6K
Open Access
Percentage
72%
Total
Publications
121
Total Open
Publications
87
Total
Citations
6K
Breakdown
Publisher Open
6%
Both
35%
Other Platform Open
31%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
12
Hybrid 14%
7
No Guarantees 62%
31
Other Platform Open
Domain 96%
77
Public 6%
5
Institution 5%
4
Other Internet 4%
3
Preprint 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 77 |
Europe PMC | Domain | 62 |
Semantic Scholar | Public | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE UNDEFINED | Other Internet | 2 |
CiteSeer X | Other Internet | 2 |
Cardiff University - ORCA Online Research @Cardiff | Institution | 2 |
bioRxiv | Preprint | 2 |
usu.edu OAI-PMH Repository | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |